Non Invasive Prenatal Testing (NIPT) Market To Deliver Prominent Growth & Striking Opportunities During 2031 |Ge Healthcare (General Electric Company), Koninklijke Philips N.V., Illumina, Inc., Thermo Fisher Scientific, F. Hoffman-La Roche Ltd.

New York, Global Non Invasive Prenatal Testing (NIPT) Market report from Global Insight Services is the single authoritative source of intelligence on Non Invasive Prenatal Testing (NIPT) Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.

Download sample report:https://www.globalinsightservices.com/request-sample/GIS22045/

NIPT is a prenatal screening test that can be used to determine the risk of a fetus having certain chromosomal abnormalities, such as Down syndrome. NIPT is a blood test that is typically performed on pregnant women who are considered to be at high risk for these conditions, based on their age or other factors. The test can also be used to screen for other conditions, such as Edwards syndrome and Patau syndrome.

Key Players

The Non Invasive Prenatal Testing (NIPT) Market report includes players such as Ge Healthcare (General Electric Company), Koninklijke Philips N.V., Illumina, Inc., Thermo Fisher Scientific, F. Hoffman-La Roche Ltd., Pacific Biosciences of California, Inc., Perkinelmer, Inc., Qiagen N.V., Agilent Technologies, Inc., and Beijing Genomics Institute.

Get Customized Report as Per Your Requirement: https://www.globalinsightservices.com/request-customization/GIS22045

Key Trends

Non-invasive prenatal testing (NIPT) is a rapidly evolving field with new technology emerging all the time. The key trends in NIPT technology include:

1. Increased accuracy: NIPT is becoming increasingly accurate, with some tests now able to detect fetal chromosomal abnormalities with greater than 99% accuracy.

2. Earlier detection: NIPT can be performed earlier in pregnancy than traditional prenatal testing, meaning that parents can find out about potential problems sooner.

3. Non-invasive: As the name suggests, NIPT is a completely non-invasive procedure, which is much safer for both mother and baby than traditional invasive prenatal tests.

4. Lower cost: The cost of NIPT is falling as the technology becomes more widely available.

Key Drivers

The key drivers of the Non-Invasive Prenatal Testing (NIPT) market are the increasing incidences of chromosomal anomalies and the rising demand for the early detection of genetic disorders. The NIPT market is expected to grow at a significant rate in the coming years, owing to the increasing awareness about the benefits of NIPT and the availability of advanced NIPT technologies.

The number of births with chromosomal anomalies has been increasing globally, owing to the rising number of older women opting for pregnancy and the increasing number of multiple births. The increasing number of births with chromosomal anomalies is expected to drive the growth of the NIPT market.

The demand for early detection of genetic disorders is also expected to boost the growth of the NIPT market. NIPT can be used to detect a wide range of genetic disorders, such as Down syndrome, Edwards syndrome, and Patau syndrome. NIPT is a highly accurate test and can be performed as early as 10 weeks into the pregnancy. The availability of advanced NIPT technologies, such as next-generation sequencing (NGS) and digital PCR, is expected to drive the growth of the NIPT market.

Market Segments

The Non Invasive Prenatal Testing (NIPT) Market is basis of product, method, application, and region. Based on product, it is bifurcated into consumables and instruments. Based on method, it is divided into ultrasound detection, biochemical screening tests, cell-free DNA in maternal plasma tests, and fetal cells in maternal blood tests. Based on application, it can be categorized into trisomy, microdeletion syndrome, and other applications. Region-wise, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World.

Purchase This Market Research Report -https://www.globalinsightservices.com/checkout/single_user/GIS22045

With Global Insight Services, you receive:

• 10-year forecast to help you make strategic decisions
• In-depth segmentation which can be customized as per your requirements
• Free consultation with lead analyst of the report
• Excel data pack included with all report purchases
• Robust and transparent research methodology

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.